Billionaire twins–backed stock surges 100% after buying $50M ‘encrypted Bitcoin’

Core Insights - Leap Therapeutics is rebranding to Cypherpunk Technologies Inc., transitioning from a biotech firm to a crypto treasury firm focused on accumulating Zcash's native coin, ZEC [1] - The company has utilized $50 million from a private placement to acquire 203,775.27 ZEC at an average price of $245.37 per coin [2] - Cypherpunk secured $58.88 million in a private placement led by Winklevoss Capital, resulting in a significant stock price increase of over 100% to $87.55 [4] Company Strategy - Cypherpunk aims to accumulate Zcash, targeting ownership of at least 5% of the total ZEC supply, as stated by CEO Tyler Winklevoss [6] - The company is positioning itself to support privacy-protecting assets and technologies, emphasizing its dedication to privacy and self-sovereignty [6] Market Positioning - Zcash is described as a privacy-focused cryptocurrency, utilizing zero-knowledge proofs (zk-SNARKs) to enhance transaction privacy [5] - Tyler Winklevoss compares Zcash to Bitcoin, suggesting that while Bitcoin serves as digital gold, Zcash functions as encrypted digital cash [7] - The company believes that Zcash could capture a meaningful percentage of Bitcoin's market capitalization as the world enters the AI age [7] Future Outlook - Predictions indicate that Bitcoin could reach a price of $1 million within the next 5-10 years, with Zcash also expected to grow [8]